FineMark National Bank & Trust’s Prestige Consumer Healthcare PBH Stock Holding History

FineMark National Bank & Trust’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-154	Closed	-$8K	–	811
2016 Q4	$8K	Hold	154	–	–	﹤0.01%	1002
2016 Q3	$7K	Sell	154 -261	-63%	-$13.2K	﹤0.01%	1017
2016 Q2	$23K	Buy	+415	New	+$22.9K	﹤0.01%	798
2016 Q1	–	Sell	-200	Closed	-$10K	–	1348
2015 Q4	$10K	Hold	200	–	–	﹤0.01%	943
2015 Q3	$9K	Hold	200	–	–	﹤0.01%	994
2015 Q2	$9K	Hold	200	–	–	﹤0.01%	1021
2015 Q1	$9K	Hold	200	–	–	﹤0.01%	1025
2014 Q4	$7K	Buy	+200	New	+$6.64K	﹤0.01%	1091

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MRCP

Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FineMark National Bank & Trust's PBH Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Prestige Consumer Healthcare (PBH) in Q1 2017, closing a stake of 154 shares — an estimated $8K sold.

FineMark National Bank & Trust first reported a position in PBH in Q4 2014 and held it in 8 quarters. The position peaked at $23K in Q2 2016. 240 funds tracked by Wall St. Rank hold PBH as of Q1 2017.

FineMark National Bank & Trust reported no remaining Prestige Consumer Healthcare position as of Q1 2017 after selling out during the quarter.
FineMark National Bank & Trust sold 154 Prestige Consumer Healthcare shares in Q1 2017, an estimated $8K.
FineMark National Bank & Trust first reported a position in Prestige Consumer Healthcare in Q4 2014 and held it in 8 quarters.
FineMark National Bank & Trust's Prestige Consumer Healthcare position peaked at $23K in Q2 2016.
240 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.